Kévin Alessandri

Kévin Alessandri is a French scientist and entrepreneur who is currently the co-founder and vice president U.S. of TreeFrog Therapeutics. Kévin was previously a postdoctoral fellow at Institut d'Optique and UNIGE Biochemistry Department, and obtained their PhD from Institut Curie in 2013. From 2000 to 2006, they worked as a video technician for AMP VISUAL TV.

Kévin Alessandri received a Doctor of Philosophy (Ph.D.) in Physics from Institut Curie and was awarded the Biophysic thesis award from Fondation Pierre-Gilles de Gennes. Kévin also holds a Diplôme de École Normale Supérieure in Genetics from École Normale Supérieure and a Diplôme de l'Institut Pasteur in Cell/Cellular Biology from Institut Pasteur. In addition, Kévin Alessandri holds a Master's degree in Neurobiology from École Normale Supérieure et Université Pierre et Marie Curie and a Bachelor of Science (BS) in Biochemistry and Genetics from Pierre and Marie Curie University.

They are on a team with Fabien Moncaubeig - CDO, Pascale Berthet - CBDO, and Gabriel Chaigneau - CFO. Their manager is Frédéric Desdouits, CEO.